Genomma Plans Stock Buyback

Mexican pharmaceuticals company Genomma Lab plans to launch next week a program to buy back up to MXP100m of its stock. The pharmaceuticals maker which went public in June 2008 has 530m shares outstanding. The shares closed Monday at MXP9.51, representing a decline of 41% since debuting at MXP16.